Skip to content

Colorectal Cancer Screening in Alaska Native Men

Increasing Colorectal Cancer Screening in Alaska Native Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06436300
Enrollment
998
Registered
2024-05-31
Start date
2023-08-01
Completion date
2024-01-31
Last updated
2025-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Keywords

screening

Brief summary

Alaska Native men have the highest rates of colorectal cancer incidence and mortality in the US. Screening can prevent disease and improve survival. A previous study tested text messages to increase colorectal cancer screening in Alaska Native patients of the Southcentral Foundation healthcare system in Anchorage, Alaska. The intervention improved screening by 50% in women, but it had no effect in men. The current study aimed to culturally tailor the intervention for Alaska Native Men, and to test it with a randomized controlled trial among patients at the Southcentral Foundation.

Detailed description

Alaska Native men have higher colorectal cancer (CRC) incidence and mortality than any other US racial or ethnic group. Screening can prevent CRC and improve treatment outcomes by detecting disease in early stages, but Alaska Native men also have low CRC screening uptake. Colonoscopy is the most accurate CRC screening method and results in the most years of life saved. It only requires rescreening every 10 years, but it is a clinic- based procedure and needs extensive preparation. Other screening options include home-based tests that detect blood in the stool and require rescreening every year. More recently, a home-based method has been developed that tests stool for DNA indicative of CRC and requires rescreening every 3 years. Current guidelines recommend CRC screening for average risk adults starting between ages 45-50, but people at higher risk should start at younger ages. Many interventions have been developed to promote CRC screening. Among these, interventions that use text messaging or other electronic health messages to reach people outside of the clinical setting have shown promise for improving CRC screening. In a previous study, the research team developed an intervention that sends up to 3 text messages to Alaska Native people patients of the Southcentral Foundation (SCF) healthcare system in Anchorage, Alaska. The intervention was tested in a randomized controlled trial with 2,386 Alaska Native SCF patients ages 40-75. The intervention increased CRC screening by 50% in women, but it had no effect in men. The current study used a theory-based approach to culturally tailor the previous text message intervention for Alaska Native men. Investigators conducted a randomized trial to test the effectiveness of the tailored intervention with 998 Alaska Native men ages 40-75 who were active patients at SCF. Eligible men were identified from the electronic medical record and randomized in equal proportions to the control condition or to one of three intervention arms (messages only, messages plus gift card incentive, messages plus raffle incentive). The primary outcomes were completed CRC screening documented in the electronic medical record within 6 months of sending the first text message, and any scheduled visit for pre-screening or screening documented in the medical record during follow-up. The study obtained a waiver of consent, and no individuals were directly recruited or enrolled in the study. Follow-up was entirely ascertained through the electronic medical record, and cohort attrition was not applicable.

Interventions

Intervention sends up to 4 motivational messages by text or email to Alaska Native men who are active patients and due for colorectal cancer screening. Incentive arms include promise of a $50 gift card or entry into a raffle for prize worth about $200 if they complete screening.

Sponsors

Southcentral Foundation
CollaboratorOTHER
Washington State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Parallel arm randomized controlled trial

Eligibility

Sex/Gender
MALE
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Alaska Native or American Indian racial identity * Male gender identity * Active patient of the Southcentral Foundation in Anchorage, Alaska * Empanelled to primary care provider in the Anchorage or local Valley area * Eligible for routine preventive colorectal cancer screening

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Completed Colorectal Cancer ScreeningSix monthsScreening procedure documented in the electronic medical record
Number of Participants Who Scheduled a Screening-related VisitSix monthsPre-screening or screening visit scheduled in the electronic medical record during follow-up

Countries

United States

Participant flow

Recruitment details

The trial obtained a waiver of consent, and no individuals were directly recruited or enrolled. Screening-eligible men who met all other criteria were identified in the electronic health record and randomly sampled for inclusion in the study cohort.

Pre-assignment details

Prior to sending the first electronic message, we re-queried the electronic health record and removed men who had completed colorectal screening in the interval between randomization and launching the trial.

Participants by arm

ArmCount
Control
The control arm received usual care for colorectal cancer screening outreach, and did not receive any study-related electronic messages.
250
Messages
This arm received electronic messages to promote colorectal cancer screening, but did not receive any notices about additional incentives.
250
Gift Card
This arm received the same electronic messages as the Messages arm, and was additionally promised a $50 gift card if they completed colorectal screening by the target date.
248
Raffle
This arm received the same electronic messages as the Messages arm, and were additionally promised they would be added to a raffle (\ $200 prize value) if they completed screening before a target date.
250
Total998

Baseline characteristics

CharacteristicGift CardControlMessagesRaffleTotal
Age, Customized
40-44 years
87 Participants78 Participants82 Participants79 Participants326 Participants
Age, Customized
45-49 years
40 Participants47 Participants47 Participants47 Participants181 Participants
Age, Customized
50-54 years
39 Participants46 Participants40 Participants29 Participants154 Participants
Age, Customized
55-59 years
26 Participants29 Participants29 Participants32 Participants116 Participants
Age, Customized
60-65 years
56 Participants50 Participants52 Participants63 Participants221 Participants
Previous screening
Not previously screened
212 Participants214 Participants210 Participants210 Participants846 Participants
Previous screening
Previously screened
36 Participants36 Participants40 Participants40 Participants152 Participants
Race (NIH/OMB)
American Indian or Alaska Native
248 Participants250 Participants250 Participants250 Participants998 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants0 Participants0 Participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants0 Participants0 Participants
Sex: Female, Male
Male
248 Participants250 Participants250 Participants250 Participants998 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 2500 / 2500 / 2480 / 250
other
Total, other adverse events
0 / 2500 / 2500 / 2480 / 250
serious
Total, serious adverse events
0 / 2500 / 2500 / 2480 / 250

Outcome results

Primary

Number of Participants Who Completed Colorectal Cancer Screening

Screening procedure documented in the electronic medical record

Time frame: Six months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Participants Who Completed Colorectal Cancer ScreeningAny screening documented11 Participants
ControlNumber of Participants Who Completed Colorectal Cancer ScreeningNo screening documented239 Participants
MessagesNumber of Participants Who Completed Colorectal Cancer ScreeningNo screening documented234 Participants
MessagesNumber of Participants Who Completed Colorectal Cancer ScreeningAny screening documented16 Participants
Gift CardNumber of Participants Who Completed Colorectal Cancer ScreeningAny screening documented18 Participants
Gift CardNumber of Participants Who Completed Colorectal Cancer ScreeningNo screening documented230 Participants
RaffleNumber of Participants Who Completed Colorectal Cancer ScreeningAny screening documented19 Participants
RaffleNumber of Participants Who Completed Colorectal Cancer ScreeningNo screening documented231 Participants
Primary

Number of Participants Who Scheduled a Screening-related Visit

Pre-screening or screening visit scheduled in the electronic medical record during follow-up

Time frame: Six months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Participants Who Scheduled a Screening-related VisitVisit scheduled8 Participants
ControlNumber of Participants Who Scheduled a Screening-related VisitNo visit scheduled242 Participants
MessagesNumber of Participants Who Scheduled a Screening-related VisitNo visit scheduled230 Participants
MessagesNumber of Participants Who Scheduled a Screening-related VisitVisit scheduled20 Participants
Gift CardNumber of Participants Who Scheduled a Screening-related VisitVisit scheduled18 Participants
Gift CardNumber of Participants Who Scheduled a Screening-related VisitNo visit scheduled230 Participants
RaffleNumber of Participants Who Scheduled a Screening-related VisitVisit scheduled17 Participants
RaffleNumber of Participants Who Scheduled a Screening-related VisitNo visit scheduled233 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026